# Ark 21Shares Bitcoin ETF: financial statements, quarterly

ARKB · CBOE · CIK 1869699 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/arkb.md) · [Financials](/companies/arkb/financials.md) · [Filings](/companies/arkb/filings.md) · [Insiders](/companies/arkb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/arkb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating income | $m | [(0.6)](/filings/0001213900-26-021831.md) | [(1.6)](/filings/0001213900-26-021831.md) | [(1.5)](/filings/0001213900-26-021831.md) | [(2.1)](/filings/0001213900-26-021831.md) | [(2.4)](/filings/0001213900-26-053859.md) | [(2.4)](/filings/0001213900-26-086191.md) | [(2.8)](/filings/0001213900-26-021831.md) | [(2.2)](/filings/0001213900-26-021831.md) | [(1.4)](/filings/0001213900-26-053859.md) | [(1.3)](/filings/0001213900-26-086191.md) |
| Net income | $m | [845](/filings/0001213900-26-021831.md) | [(409)](/filings/0001213900-26-021831.md) | [46.1](/filings/0001213900-26-021831.md) | [1,410](/filings/0001213900-26-021831.md) | [(588)](/filings/0001213900-26-053859.md) | [1,198](/filings/0001213900-26-086191.md) | [318](/filings/0001213900-26-021831.md) | [(1,150)](/filings/0001213900-26-021831.md) | [(717)](/filings/0001213900-26-053859.md) | [(275)](/filings/0001213900-26-086191.md) |

- Operating income: us-gaap:OperatingIncomeLoss
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | period not labelled (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.0](/filings/0001213900-24-026067.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [0.0](/filings/0001213900-24-026067.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | not reported | [3,188](/filings/0001213900-24-042279.md) | [2,898](/filings/0001213900-24-067165.md) | [3,217](/filings/0001213900-24-096769.md) | [4,364](/filings/0001213900-26-021831.md) | [3,939](/filings/0001213900-25-042727.md) | [5,045](/filings/0001213900-25-075771.md) | [5,199](/filings/0001213900-25-110782.md) | [3,382](/filings/0001213900-26-086191.md) | [2,390](/filings/0001213900-26-053859.md) | [1,889](/filings/0001213900-26-086191.md) |
| Total liabilities | $m | not reported | [28.3](/filings/0001213900-24-042279.md) | [48.4](/filings/0001213900-24-067165.md) | [10.6](/filings/0001213900-24-096769.md) | [11.6](/filings/0001213900-26-021831.md) | [23.9](/filings/0001213900-25-042727.md) | [10.4](/filings/0001213900-25-075771.md) | [106](/filings/0001213900-25-110782.md) | [76.6](/filings/0001213900-26-086191.md) | [1.2](/filings/0001213900-26-053859.md) | [0.1](/filings/0001213900-26-086191.md) |
| Shareholders' equity | $m | [(0.0)](/filings/0001213900-25-110782.md) | [3,160](/filings/0001213900-25-075771.md) | [2,850](/filings/0001213900-25-110782.md) | [3,206](/filings/0001213900-25-110782.md) | [4,352](/filings/0001213900-26-086191.md) | [3,915](/filings/0001213900-26-086191.md) | [5,034](/filings/0001213900-26-086191.md) | [5,093](/filings/0001213900-25-110782.md) | [3,305](/filings/0001213900-26-086191.md) | [2,389](/filings/0001213900-26-086191.md) | [1,889](/filings/0001213900-26-086191.md) |

- Cash and equivalents: us-gaap:Cash
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

Shares outstanding: 101,190,000 at 2026-08-03, from the cover of the [10-Q filed 2026-08-06](/filings/0001213900-26-086191.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.